S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call|
|Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference|
|Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update|
|Avanir Pharmaceuticals to Participate in Two Conferences in August|
|Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder|
|Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease|
|Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock|
|Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock|
|Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares|
|Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014|
Click above to view more mutual fund data and stats for avnr - AVANIR Pharmaceuticals Class A.